Markets:

Overview

News

Currencies

International

Treasuries

ARK Genomic Revolution ETF (NY:ARKG)

41.97 +1.86 (+4.64%)

Streaming Delayed Price Updated: 11:57 AM EDT, Jun 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ARK Genomic Revolution ETF

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

10 Best Stocks to Buy in March 2023 ↗

March 01, 2023

These diversified growth stocks could add rocket fuel to your long-term investment portfolio.

Via The Motley Fool

Cathie Wood Makes Biggest Coinbase Purchase Of Year After Earnings Beat ↗

February 23, 2023

Cathie Wood and her ARK Invest firm bought $13 million in COIN stock as they bulk up holdings following Coinbase earnings.

Via Investor's Business Daily

3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street ↗

February 07, 2023

These stocks are risky. But they just might deliver huge gains if analysts are right.

Via The Motley Fool

When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader? ↗

February 05, 2023

A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy?

Via Talk Markets

Cathie Wood Trims Robinhood Stake As Stock Gains 28% In January — Also Offloads Shares In This Biotech Company ↗

January 31, 2023

Cathie Wood-led ARK Investment Management sold 85,337 shares of financial services company Robinhood Markets Inc (NASDAQ: HOOD) at

Via Benzinga

Why Teladoc Stock Popped 5% Today ↗

January 27, 2023

Cathie Wood keeps buying shares of the telemedicine company. Should you?

Via The Motley Fool

Healthcare Sector Is Lagging As We Enter 2022 Earnings Season ↗

January 23, 2023

The healthcare sector is perceived as defensive but in 2023 there is more investor appetite for risk based on the QQQ comeback and the XBI strength.

Via Talk Markets

Don't Call It A Comeback: Cathie Wood Is Beating The S&P 500 In Early 2023 ↗

January 23, 2023

The competition could be paying the price in 2023 if Ark Invest can keep up with its early performance at the start of the year.

Via Benzinga

J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps ↗

January 17, 2023

Large cap biopharmas that outperformed in 2022 were generally weak last week from profit-taking and portfolio rebalancing.

Via Talk Markets

Cathie Wood Makes This Molecular Diagnostics Company Top Holding Of Ark Invest's Flagship Fund, Catapulting Past Zoom, Tesla ↗

January 11, 2023

Shares of Exact Sciences, Inc. (NASDAQ: EXAS) have been on a tear, having gained over 27% in two sessions this week.

Via Benzinga

Cathie Wood Gets Elon Musk's Attention Over Gene-Editing Therapy Potential: 'Investors Chased The Dream Then. Now, They're Running Away' ↗

January 04, 2023

Cathie Wood of ARK Investment Management believes U.S. equity markets are the polar opposite of what they were in the 90s when investors chased their dreams.

Via Benzinga

War, Inflation, Fed Hawkishness, Elon Musk's Twitter Buy: How These Factors Weighed On Cathie Wood's Top Holdings In 2022 ↗

January 02, 2023

In 2022, financial markets witnessed one of the worst routs in history, dragged by the war in Ukraine, rising inflation and subsequent hawkish policies deployed by central banks.

Via Benzinga

Precious Metals Outperformed Stocks And Bonds In 2022 ↗

December 30, 2022

The power of silver's rebound has surprised many, even its most ardent supporters.

Via Talk Markets

2 Cathie Wood Stocks to Buy and Hold Through 2023 and Beyond ↗

December 29, 2022

These two biotechs are flying high right now.

Via The Motley Fool

'Study The Mindset Of Stonk Hodlers': This Fund Manager Rips Cathie Wood's Investment Strategy ↗

December 22, 2022

ETF fund manager Cathie Wood is known for investing in growth stocks and what she has labeled as “innovation.” A take by the fund manager drew criticism from a hedge fund manager.

Via Benzinga

Cathie Wood Adds $7M Of This Clinical-Stage Biotech, Trims Stake In CVS-Target Signify Health ↗

December 07, 2022

Cathie Wood-led ARK Investment Management bought over 330,000 shares of clinical-stage biotechnology company Verve Therapeutics Inc (NASDAQ: VERV) at an estimated valuation of over $6.9 million, based...

Via Benzinga

Getting Ready For The Coming Stock Market Elevator Drop ↗

December 04, 2022

In this video Kirk Spano updates trends in Global ETFs and discusses why he thinks stocks are headed down in a big way.

Via Talk Markets

This Congressman Just Purchased 2 Stocks Which Consistently Increase Dividends ↗

November 28, 2022

Congressman Dwight Evans (D-PA) has represented Pennsylvania's Third Congressional District since 2019, and has made over 70 trades in the past three years. His top two traded investments are Intel...

Via Benzinga

Cathie Wood Has Bet Big On These 10 Stocks; Here's How They're Performing ↗

November 28, 2022

Here's how Ark Invest's top holdings have performed in 2022.

Via Investor's Business Daily

Cathie Wood Is Selling This High-Flying Stock. Here's Why You Should Buy It Instead ↗

November 25, 2022

The ARK Invest founder might regret trimming her position in this biotech stock.

Via The Motley Fool

Cathie Wood Increases Stake In 4 Stocks By Over 1,000% - Plus 4 New Holdings For Ark ↗

November 22, 2022

Cathie Wood’s ARK Innovation ETF (ARCA: ARKK) is down roughly 63% year-to-date, compared to the NASDAQ which is down at least 29% year-to-date and the S&P 500 down over 16% year-to-date.

Via Benzinga

Cathie Wood Teams Up With This Investment Bank To Offer Ark Invest's ETFs In Canada ↗

November 19, 2022

Cathie Wood’s Ark Invest, this week, announced a deal with Canadian investment manager BMO Capital Markets.

Via Benzinga

Cathie Wood Loads Up Over $6.7M In Adobe Stock As It Tumbles 27% In A Month — Also Adds Stake In This Biopharma Company ↗

October 10, 2022

Cathie Wood-led ARK Investment Management bought over 23,000 shares of software maker Adobe Inc (NASDAQ: ADBE) through the

Via Benzinga

ARK Invest Short Sellers Have $2.3B In Profits So Far In 2022 ↗

September 30, 2022

After a horrible 2021 for Cathie Wood, the ARK Innovation ETF (NYSE: ARKK) is down another 59.1% in 2022. High-growth tech stocks have taken a beating as interest rates have spiked, sending ARK Invest...

Via Benzinga

Cathie Wood Sells $2.8M In Healthcare Stock Buoyed By Amazon-Linked Rumors ↗

September 28, 2022

Cathie Wood-led Ark Investment Management on Wednesday sold 96,746 shares of Signify Health Inc. (NYSE: SGFY), estimated to be valued at around $2.8 million.

Via Benzinga

Cathie Wood Splurges $22M To Hike Stake In This Chipmaker Stock Worrying Jim Cramer ↗

September 26, 2022

Cathie Wood’s Ark Investment Management on Monday hiked its stake in chip manufacturer Nvidia Corporation (NASDAQ: NVDA) via the ARK Genomic Revolution ETF (NYSE: ARKG).

Via Benzinga

Cathie Wood Loads Up $23M Worth Of Shares In This Gene-Editing Company As Stock Falls Over 10% In A Month ↗

September 25, 2022

Cathie Wood-led Ark Investment Management on Friday raised its stake in clinical stage genetics medicine company Verve Therapeutics Inc (NASDAQ: VERV) via two of its exchange-traded funds.

Via Benzinga

Cathie Wood Buys Nearly $7M In This Sapped Bitcoin-Linked Stock — Also Picks Up Shares In CareDx ↗

September 14, 2022

Cathie Wood-led Ark Investment Management has bought over 100,000 shares of Jack Dorsey’s Block Inc (NYSE: SQ), valued at over $6.9 million based on Wednesday’s closing price.

Via Benzinga

Benzinga Before The Bell: Tesla Sues Louisiana Automobile Dealers Association, Will iPhone 14 Feature Satellite Connectivity?, Netflix Denies $7 To $9 Ad-Supported Plan And Other Top Financial Stories Tuesday, August 30 ↗

August 30, 2022

Reuters Taiwan’s China Airlines Orders 16 Boeing 787s

Via Benzinga

Cathie Wood Loads Up $3M In This Precision Medicine Firm's Shares Despite Bleak Q2 Results ↗

August 30, 2022

Cathie Wood-led Ark Investment Management loaded up on 153,917 shares of precision medicine company CareDx Inc (NASDAQ: CDNA), via the ARK Genomic Revolution ETF (NYSE: ARKG<

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.